MEDNATION AG(FRA:EIF) stock Fundamental Analysis

Fundamental Rating

Overall EIF gets a fundamental rating of 4 out of 10. We evaluated EIF against 23 industry peers in the Health Care Providers & Services industry. EIF has only an average score on both its financial health and profitability. EIF has a valuation in line with the averages, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EIF was profitable.

In the past year EIF had a positive cash flow from operations.

EIF had negative earnings in 4 of the past 5 years.

Each year in the past 5 years EIF had a positive operating cash flow.

1.2 Ratios

With a decent Return On Assets value of 4.34%, EIF is doing good in the industry, outperforming 76.92% of the companies in the same industry.

Looking at the Return On Equity, with a value of 26.01%, EIF belongs to the top of the industry, outperforming 96.15% of the companies in the same industry.

With a decent Return On Invested Capital value of 7.11%, EIF is doing good in the industry, outperforming 73.08% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	4.34%
ROE	26.01%
ROIC	7.11%

ROA(3y)-1.65%

ROA(5y)-1.59%

ROE(3y)-14.96%

ROE(5y)-11.92%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

EIF has a Profit Margin of 6.64%. This is amongst the best in the industry. EIF outperforms 92.31% of its industry peers.

EIF has a better Operating Margin (13.53%) than 96.15% of its industry peers.

EIF's Operating Margin has improved in the last couple of years.

The Gross Margin of EIF (82.96%) is better than 84.62% of its industry peers.

EIF's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	13.53%
PM (TTM)	6.64%
GM	82.96%

OM growth 3Y49.73%

OM growth 5Y95.02%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.01%

GM growth 5Y-0.44%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

EIF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.

The number of shares outstanding for EIF remains at a similar level compared to 1 year ago.

EIF has about the same amout of shares outstanding than it did 5 years ago.

Compared to 1 year ago, EIF has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.02, we must say that EIF is in the distress zone and has some risk of bankruptcy.

EIF has a Altman-Z score (1.02) which is in line with its industry peers.

The Debt to FCF ratio of EIF is 3.92, which is a good value as it means it would take EIF, 3.92 years of fcf income to pay off all of its debts.

EIF has a Debt to FCF ratio of 3.92. This is amongst the best in the industry. EIF outperforms 80.77% of its industry peers.

A Debt/Equity ratio of 1.01 is on the high side and indicates that EIF has dependencies on debt financing.

With a Debt to Equity ratio value of 1.01, EIF perfoms like the industry average, outperforming 42.31% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	1.01
Debt/FCF	3.92
Altman-Z	1.02

ROIC/WACC1.49

WACC4.77%

2.3 Liquidity

A Current Ratio of 1.11 indicates that EIF should not have too much problems paying its short term obligations.

EIF has a Current ratio of 1.11. This is in the better half of the industry: EIF outperforms 69.23% of its industry peers.

EIF has a Quick Ratio of 1.08. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.08, EIF belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.11
Quick Ratio	1.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 257.21% over the past year.

Looking at the last year, EIF shows a quite strong growth in Revenue. The Revenue has grown by 15.42% in the last year.

Measured over the past years, EIF shows a decrease in Revenue. The Revenue has been decreasing by -2.42% on average per year.

EPS 1Y (TTM)257.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%156.41%

Revenue 1Y (TTM)15.42%

Revenue growth 3Y7.14%

Revenue growth 5Y-2.42%

Sales Q2Q%12.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 1.32, the valuation of EIF can be described as very cheap.

Based on the Price/Earnings ratio, EIF is valued cheaper than 100.00% of the companies in the same industry.

Compared to an average S&P500 Price/Earnings ratio of 29.35, EIF is valued rather cheaply.

		Industry Rank	Sector Rank
PE	1.32
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EIF is valued cheaply inside the industry as 96.15% of the companies are valued more expensively.

Based on the Price/Free Cash Flow ratio, EIF is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	1.29
EV/EBITDA	1.56

4.3 Compensation for Growth

The decent profitability rating of EIF may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for EIF!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MEDNATION AG

FRA:EIF (3/7/2025, 7:00:00 PM)

1.35

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)09-30 2024-09-30

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners25.13%

Ins Owner ChangeN/A

Market Cap4.21M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	1.32
Fwd PE	N/A
P/S	0.09
P/FCF	1.29
P/OCF	1.12
P/B	0.36
P/tB	0.36
EV/EBITDA	1.56

EPS(TTM)1.02

EY75.56%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)1.04

FCFY77.33%

OCF(TTM)1.2

OCFY88.91%

SpS14.82

BVpS3.79

TBVpS3.77

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	4.34%
ROE	26.01%
ROCE	10.1%
ROIC	7.11%
ROICexc	7.37%
ROICexgc	7.37%
OM	13.53%
PM (TTM)	6.64%
GM	82.96%
FCFM	7.04%

ROA(3y)-1.65%

ROA(5y)-1.59%

ROE(3y)-14.96%

ROE(5y)-11.92%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y55.71%

ROICexcg growth 5Y72.19%

ROICexc growth 3Y55.69%

ROICexc growth 5Y72.32%

OM growth 3Y49.73%

OM growth 5Y95.02%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.01%

GM growth 5Y-0.44%

F-Score8

Asset Turnover0.65

Health

		Industry Rank	Sector Rank
Debt/Equity	1.01
Debt/FCF	3.92
Debt/EBITDA	1.25
Cap/Depr	14.98%
Cap/Sales	1.06%
Interest Coverage	2.22
Cash Conversion	39.35%
Profit Quality	106.03%
Current Ratio	1.11
Quick Ratio	1.08
Altman-Z	1.02

F-Score8

WACC4.77%

ROIC/WACC1.49

Cap/Depr(3y)10.83%

Cap/Depr(5y)12.76%

Cap/Sales(3y)1.47%

Cap/Sales(5y)1.67%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)257.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%156.41%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)15.42%

Revenue growth 3Y7.14%

Revenue growth 5Y-2.42%

Sales Q2Q%12.48%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y397.39%

EBIT growth 3Y60.43%

EBIT growth 5Y90.31%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y9.66%

FCF growth 3Y-19.45%

FCF growth 5YN/A

OCF growth 1Y-5.74%

OCF growth 3Y-18.01%

OCF growth 5Y53.19%

MEDNATION AG (EIF.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens